Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MEDXF - Medexus Pharmaceuticals Inc. (MEDXF) CEO Ken D'Entremont On Q2 2022 Results - Earnings Call Transcript

MEDXF - Medexus Pharmaceuticals Inc. (MEDXF) CEO Ken D'Entremont On Q2 2022 Results - Earnings Call Transcript

Medexus Pharmaceuticals Inc
Medexus Pharmaceuticals, Inc. (MEDXF) Q2 2022 Earnings Conference Call November 11, 2021 8:00 AM ET Company Participants Tina Byers - IR Ken d’Entremont - CEO Marcel Konrad - CFO Conference Call Participants Justin Keywood - Stifel GMP Andre Uddin - Research Capital Prasath Pandurangan - Bloom Burton Securities Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Operator 00:04 Good day, ladies and gentlemen, and welcome to the Medexus Pharmaceuticals' Second Quarter twenty twenty two Earnings Call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for questions and comments after the presentation. [Operator Instructions] 00:18 It is now my pleasure

For further details see:

Medexus Pharmaceuticals, Inc. (MEDXF) CEO Ken D'Entremont On Q2 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Medexus Pharmaceuticals Inc
Stock Symbol: MEDXF
Market: OTC
Website: medexusinc.com
Menu
MEDXF MEDXF Quote MEDXF Short MEDXF News MEDXF Articles MEDXF Message Board
Get MEDXF Alerts

News, Short Squeeze, Breakout and More Instantly...